recombinant human nerve growth factor (Dompe Farmaceutici)

N/A

Report date: 2025/03/20 10:02:05

Base Information

Drug Namerecombinant human nerve growth factor (Dompe Farmaceutici)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionLow affinity neurotrophin receptor p75NTR agonists
TargetsLow affinity neurotrophin receptor p75NTR
Therapy Area/IndicationsRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDompé Pharmaceutici Spa
China Registration ClassN/A

Develop Information

Active CompaniesDompé Pharmaceutici Spa
Inactive CompaniesN/A
Active IndicationsRett Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A